Literature DB >> 6238642

Plasma protein S deficiency in familial thrombotic disease.

H P Schwarz, M Fischer, P Hopmeier, M A Batard, J H Griffin.   

Abstract

A family with a history of severe recurrent venous thromboembolic disease was studied to determine if a plasma protein deficiency could account for observed disease. Protein S levels in plasma were determined immunologically using the Laurell rocket technique. The propositus, his mother, his aunt, and his cousin who were clinically affected had 17% to 65% of the control levels of protein S antigen (normal range, 71% to 147%). Since three of these patients were receiving oral anticoagulant therapy, the ratios of protein S to prothrombin, factor X, and protein C in these patients were compared with values for a group of orally anticoagulated controls. These results suggested that protein S is half-normal in all family members with thrombotic disease. Other proteins known to be associated with familial thrombotic disease, including antithrombin III, plasminogen, fibrinogen, and protein C, were normal. Because plasma protein S serves as a cofactor for the anticoagulant activity of activated protein C and because protein C deficiency is associated with recurrent thrombotic disease, it is suggested that recurrent thrombotic disease in this family is the result of an inherited deficiency of protein S.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238642

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  69 in total

Review 1.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S.

Authors:  T M Hackeng; J A Fernández; P E Dawson; S B Kent; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

3.  Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

Authors:  S T Smiley; S N Boyer; M J Heeb; J H Griffin; M J Grusby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Authors:  Carolyn L Westhoff; Malcolm C Pike; Serge Cremers; Andrew Eisenberger; Stella Thomassen; Jan Rosing
Journal:  Contraception       Date:  2017-01-11       Impact factor: 3.375

Review 5.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

Review 6.  [Genetic causes of impaired wound healing. Rare differential diagnosis of the non-healing wound].

Authors:  K Elsharkawi-Welt; J Hepp; K Scharffetter-Kochanek
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751

7.  Internal medicine: the protein C anticoagulant pathway and thrombosis.

Authors:  R B Francis
Journal:  West J Med       Date:  1985-07

8.  [Significance of the endothelium of the vascular wall for maintaining hemostasis].

Authors:  U Delvos; G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1985-12-16

9.  Risk factors for thrombosis in lupus patients.

Authors:  P Hasselaar; R H Derksen; L Blokzijl; M Hessing; H K Nieuwenhuis; B N Bouma; P G De Groot
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

Review 10.  Clinical relevance of protein C.

Authors:  I Pabinger
Journal:  Blut       Date:  1986-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.